Table 5.
Variable | Overall (N = 147) | NLR 2.77 (N = 81) | NLR 2.77 (N = 66) | p-value | |
All cause death | 37 (25.17%) | 9 (11.11%) | 28 (42.42%) | 0.000* | |
Aneurysm-related death | 2 (1.36%) | 0 (0%) | 2 (3.03%) | 0.115 | |
MACE | 15 (10.2%) | 3 (3.7%) | 12 (18.18%) | 0.004* | |
Renal failure | 2 (1.36%) | 1 (1.23%) | 1 (1.52%) | 0.884 | |
Multiple organ failure | 5 (3.4%) | 1 (1.23%) | 4 (6.06%) | 0.108 | |
Cancer | 3 (2.04%) | 1 (1.23%) | 2 (3.03%) | 0.444 | |
COVID-19 | 6 (4.08%) | 2 (2.47%) | 4 (6.06%) | 0.247 | |
Others | 4 (2.72%) | 1 (1.23%) | 3 (4.55%) | 0.220 | |
Variable | Overall (N = 147) | HRR 10.64 (N = 88) | HRR 10.64 (N = 59) | p-value | |
All cause death | 37 (25.17%) | 33 (37.5%) | 4 (6.78%) | 0.000* | |
Aneurysm-related death | 2 (1.36%) | 2 (2.27%) | 0 (0%) | 0.224 | |
MACE | 15 (10.2%) | 15 (17.05%) | 0 (0%) | 0.001* | |
Renal failure | 2 (1.36%) | 2 (2.27%) | 0 (0%) | 0.224 | |
Multiple organ failure | 5 (3.4%) | 5 (5.68%) | 0 (0%) | 0.062 | |
Cancer | 3 (2.04%) | 2 (2.27%) | 1 (1.69%) | 0.808 | |
COVID-19 | 6 (4.08%) | 3 (3.41%) | 3 (5.08%) | 0.615 | |
Others | 4 (2.72%) | 4 (4.55%) | 0 (0%) | 0.097 |
* indicates the p-value is less than 0.05.
Data are presented as n (%). MACE, major adverse cardiovascular event; COVID-19, coronavirus disease 2019.